Vitro Diagnostics Inc. (fka VODG)

[Potse]

VODG...sold my position.....

More than likely I will be looking to reduce my position if we see periods of strength in the stock during the coming months. The delinquency statement/commentary in the FY 2018 press release was basically just a repeat of what was said in the FY 2017 PR.

The SEC's unpredictable (and often ruthless) approach to delinquent filers poses a potential serious threat to VODG and its shareholders. All it takes is someone in the SEC to wake up in a foul mood some morning, throw a dart at a list of delinquent filers, and it could be "game over" for VODG if the company is not positioned to get all its filings done in a very limited period of time.

For whatever reason(s), management doesn't appear to be in any rush to eliminate the delinquency risk, and I find that somewhat alarming. Maybe they have a good reason not to be overly concerned about the suspension/revocation risk, but until they share that reason with the retail shareholders I'm not comfortable holding a large position deep into calendar 2019.

Finished selling my position awhile ago. This could very well end up being a pretty dumb move on my part, but I'm just no longer comfortable with the risk/reward at this point with the delinquency risk overhanging the stock. The company is well past that 2-3 year delinquency window when the SEC just seems to get increasingly aggressive in its suspension/revocation actions.

Based on the statements/comments in the shareholder updates, it doesn't appear to me that VODG would start filing again until maybe calendar 2020 (at the earliest). But I have this nagging feeling that management would really rather not start the filing process again, regardless of whether operational profits make SEC filings economically feasible again.

I just don't get the sense that management shares the same concern about the delinquency risk that I (and other retail investors) have. And I find that unsettling. One word of advice I would give to VODG management: The SEC is not your "friend". It will stab your company (and the retail shareholders) in the back when you least expect it.